R1 RCM : Guidance Update Call - Presentation

Guidance Update Call

June 27, 2022

Forward-Looking Statements

This presentation includes information that may constitute "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events and relationships, plans, future growth, and future performance, including, but not limited to, statements about future financial and operational performance, the expected effects and benefits of the acquisition of Cloudmed, the strategic direction of the combined company, the Company's other strategic initiatives, capital plans, costs, ability to successfully implement new technologies, and liquidity. These statements are often identified by the use of words such as "anticipate," "believe," "estimate," "expect," "intend," "designed," "may," "plan," "predict," "project," "target," "contemplate," "would," "seek," "see," and similar expressions or variations or negatives of these words, although not all forward-looking statements contain these identifying words. These statements are based on various assumptions, whether or not identified in this presentation, and on the current expectations of the Company's management and are not predictions of actual performance.

These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, assurance, prediction or definitive statement of fact or probability. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks, and changes in circumstances, including but not limited to risk and uncertainties related to: (i) the Company's ability to timely and successfully achieve the anticipated benefits and potential synergies from the acquisition of Cloudmed; (ii) the Company's ability to retain existing customers or acquire new customers; (iii) the development of markets for the Company's revenue cycle management offering; (iv) variability in the lead time of prospective customers; (v) competition within the market; (vi) breaches or failures of the Company's information security measures or unauthorized access to a customer's data; (vii) delayed or unsuccessful implementation of the Company's technologies or services, or unexpected implementation costs; (viii) disruptions in or damages to the Company's global business services centers and third-party operated data centers; and (ix) the impact of the COVID-19 pandemic on the Company's business, operating results, and financial condition. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the heading "Risk Factors" in the Company's annual report on Form 10-K for the year ended December 31, 2021, quarterly reports on Form 10-Q, the proxy statement relating to the Company's annual meeting and the acquisition of Cloudmed, and any other periodic reports that the Company may file with the United States Securities and Exchange Commission (the "SEC"). The foregoing list of factors is not exhaustive.

All forward-looking statements included herein are expressly qualified in their entirety by these cautionary statements as of the date hereof and involve many risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in the Company's forward-looking statements. Subsequent events and developments, including actual results or changes in the Company's assumptions, may cause the Company's views to change. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law. You are cautioned not to place undue reliance on such forward-looking statements.

Non-GAAP Financial Information

Some of the financial information and data contained in this presentation, including Adjusted EBITDA (and related measures), have not been prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Adjusted EBITDA may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. This non-GAAP financial measure should not be considered in isolation or as a substitute for analysis of our results of operations as reported under GAAP. Please refer to the Appendix located at the end of this presentation for a reconciliation of non-GAAP financial measures to their most directly comparable GAAP financial measure.

2

Presenters

Joseph Flanagan	Lee Rivas	Rachel Wilson
Chief Executive Officer	President	Chief Financial Officer & Treasurer

3

Transaction Recap and Cloudmed Update

4

Powerful Combination of Market-leading Platforms

Leading end-to-end technology-

driven platform to manage healthcare provider revenue

Leading data and analytics-driven

revenue intelligence platform

Strategic and Financial Highlights

• Accelerates growth by unlocking full market potential
• Extends leadership in revenue cycle automation
• Enables significant future innovation fueled by data footprint
• Flexible engagement models across all care settings
• Significant revenue and cost synergies
• Accretive to EPS and cash flow per share in 2023

5